SCHEMBL22149693

SCHEMBL22149693

C=CC(=O)N1CC(F)(C(=O)N2CCN(c3ccc(-c4cnc5ccc(Nc6cc(OC)cc(OC)c6)cc5n4)cn3)CC2)C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR3 P22607 3/20 0.48
KDR P35968 3/20 0.48
HPGD P15428 5/20 0.38
EGFR P00533 6/20 0.37
BTK Q06187 3/20 0.37
LMNA P02545 2/20 0.36
MAPK1 P28482 2/20 0.36
HSD17B10 Q99714 2/20 0.36
KDM4E B2RXH2 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ITK Q08881 2/20 0.36
NPC1 O15118 1/20 0.36
TP53 P04637 1/20 0.36
PKM P14618 1/20 0.36
TSHR P16473 1/20 0.36
RAB9A P51151 1/20 0.36
FGFR1 P11362 2/20 0.35
JAK3 P52333 1/20 0.35
FGFR2 P21802 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31655631 1.00 FGFR3 (0.48) FGFR3KDRHPGDEGFRBTK
SCHEMBL31655634 0.90 FGFR3 (0.44) FGFR3KDRHPGDEGFRBTK
SCHEMBL22149690 0.90 FGFR3 (0.44) FGFR3KDRHPGDEGFRBTK
SCHEMBL22149126 0.89 FGFR3 (0.43) FGFR3KDREGFRBTKLMNA
SCHEMBL31655629 0.89 FGFR3 (0.43) FGFR3KDREGFRBTKLMNA
SCHEMBL22149692 0.86 FGFR3 (0.50) FGFR3KDRHPGDEGFRBTK
SCHEMBL31655616 0.86 FGFR3 (0.50) FGFR3KDRHPGDEGFRBTK
SCHEMBL31655652 0.84 FGFR3 (0.53) FGFR3KDREGFRITKFGFR1
SCHEMBL22149691 0.84 FGFR3 (0.53) FGFR3KDREGFRITKFGFR1
SCHEMBL22149197 0.80 FGFR3 (0.39) FGFR3KDREGFRBTKTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020131674-A1 7-((3,5-DIMETHOXYPHENYL)AMINO)QUINOXALINE DERIVATIVES AS FGFR INHIBITORS FOR TREATING CANCER ARRAY BIOPHARMA INC. (US) 2020-06-25 WO disclosed